148 related articles for article (PubMed ID: 17110383)
1. Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14.
Borgoño CA; Michael IP; Shaw JL; Luo LY; Ghosh MC; Soosaipillai A; Grass L; Katsaros D; Diamandis EP
J Biol Chem; 2007 Jan; 282(4):2405-22. PubMed ID: 17110383
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression.
Michael IP; Sotiropoulou G; Pampalakis G; Magklara A; Ghosh M; Wasney G; Diamandis EP
J Biol Chem; 2005 Apr; 280(15):14628-35. PubMed ID: 15713679
[TBL] [Abstract][Full Text] [Related]
3. Expression and enzymatic characterization of recombinant human kallikrein 14.
Rajapakse S; Takahashi T
Zoolog Sci; 2007 Aug; 24(8):774-80. PubMed ID: 18217483
[TBL] [Abstract][Full Text] [Related]
4. The molecular function of kallikrein-related peptidase 14 demonstrates a key modulatory role in advanced prostate cancer.
Kryza T; Bock N; Lovell S; Rockstroh A; Lehman ML; Lesner A; Panchadsaram J; Silva LM; Srinivasan S; Snell CE; Williams ED; Fazli L; Gleave M; Batra J; Nelson C; Tate EW; Harris J; Hooper JD; Clements JA
Mol Oncol; 2020 Jan; 14(1):105-128. PubMed ID: 31630475
[TBL] [Abstract][Full Text] [Related]
5. Biochemical characterization of human kallikrein 8 and its possible involvement in the degradation of extracellular matrix proteins.
Rajapakse S; Ogiwara K; Takano N; Moriyama A; Takahashi T
FEBS Lett; 2005 Dec; 579(30):6879-84. PubMed ID: 16337200
[TBL] [Abstract][Full Text] [Related]
6. Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors.
Mikolajczyk SD; Millar LS; Kumar A; Saedi MS
Prostate; 1998 Jan; 34(1):44-50. PubMed ID: 9428387
[TBL] [Abstract][Full Text] [Related]
7. Characterization of mouse glandular kallikrein 24 expressed in testicular Leydig cells.
Matsui H; Takano N; Takahashi T
Int J Biochem Cell Biol; 2005 Nov; 37(11):2333-43. PubMed ID: 15985384
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors.
Magklara A; Mellati AA; Wasney GA; Little SP; Sotiropoulou G; Becker GW; Diamandis EP
Biochem Biophys Res Commun; 2003 Aug; 307(4):948-55. PubMed ID: 12878203
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic profiling of human kallikrein 14 using phage-display substrate technology.
Felber LM; Borgoño CA; Cloutier SM; Kündig C; Kishi T; Ribeiro Chagas J; Jichlinski P; Gygi CM; Leisinger HJ; Diamandis EP; Deperthes D
Biol Chem; 2005 Mar; 386(3):291-8. PubMed ID: 15843175
[TBL] [Abstract][Full Text] [Related]
10. Human kallikrein 4: enzymatic activity, inhibition, and degradation of extracellular matrix proteins.
Obiezu CV; Michael IP; Levesque MA; Diamandis EP
Biol Chem; 2006 Jun; 387(6):749-59. PubMed ID: 16800736
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of kallikrein-related peptidases by the serine protease inhibitor of Kazal-type 6.
Kantyka T; Fischer J; Wu Z; Declercq W; Reiss K; Schröder JM; Meyer-Hoffert U
Peptides; 2011 Jun; 32(6):1187-92. PubMed ID: 21439340
[TBL] [Abstract][Full Text] [Related]
12. Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitors.
Lövgren J; Airas K; Lilja H
Eur J Biochem; 1999 Jun; 262(3):781-9. PubMed ID: 10411640
[TBL] [Abstract][Full Text] [Related]
13. KLK14 interactions with HAI-1 and HAI-2 serine protease inhibitors: A molecular dynamics and relative free-energy calculations study.
Solís-Calero C; Carvalho HF
Cell Biol Int; 2017 Nov; 41(11):1246-1264. PubMed ID: 28817220
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of human kallikrein 11, a candidate prostate and ovarian cancer biomarker, from seminal plasma.
Luo LY; Shan SJ; Elliott MB; Soosaipillai A; Diamandis EP
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):742-50. PubMed ID: 16467084
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of KLK14, a novel kallikrein serine protease gene located on human chromosome 19q13.4 and expressed in prostate and skeletal muscle.
Hooper JD; Bui LT; Rae FK; Harvey TJ; Myers SA; Ashworth LK; Clements JA
Genomics; 2001 Apr; 73(1):117-22. PubMed ID: 11352573
[TBL] [Abstract][Full Text] [Related]
16. Major role of human KLK14 in seminal clot liquefaction.
Emami N; Deperthes D; Malm J; Diamandis EP
J Biol Chem; 2008 Jul; 283(28):19561-9. PubMed ID: 18482984
[TBL] [Abstract][Full Text] [Related]
17. Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum.
Stefansson K; Brattsand M; Ny A; Glas B; Egelrud T
Biol Chem; 2006 Jun; 387(6):761-8. PubMed ID: 16800737
[TBL] [Abstract][Full Text] [Related]
18. Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase.
Takayama TK; McMullen BA; Nelson PS; Matsumura M; Fujikawa K
Biochemistry; 2001 Dec; 40(50):15341-8. PubMed ID: 11735417
[TBL] [Abstract][Full Text] [Related]
19. Non-combinatorial library screening reveals subsite cooperativity and identifies new high-efficiency substrates for kallikrein-related peptidase 14.
de Veer SJ; Swedberg JE; Parker EA; Harris JM
Biol Chem; 2012 Apr; 393(5):331-41. PubMed ID: 22505516
[TBL] [Abstract][Full Text] [Related]
20. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer.
Borgoño CA; Grass L; Soosaipillai A; Yousef GM; Petraki CD; Howarth DH; Fracchioli S; Katsaros D; Diamandis EP
Cancer Res; 2003 Dec; 63(24):9032-41. PubMed ID: 14695222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
